Aging, tumor suppression and cancer: high wire-act!

[1]  Mitch Leslie,et al.  The age of cancer. , 2006, Science of aging knowledge environment : SAGE KE.

[2]  J. Campisi,et al.  Stromal-epithelial interactions in aging and cancer: senescent fibroblasts alter epithelial cell differentiation , 2004, Journal of Cell Science.

[3]  N. Barzilai,et al.  The paradox of the insulin/IGF-1 signaling pathway in longevity , 2004, Mechanisms of Ageing and Development.

[4]  T. Kunkel DNA Replication Fidelity* , 2004, Journal of Biological Chemistry.

[5]  C. Harris,et al.  p53: 25 years after its discovery. , 2004, Trends in pharmacological sciences.

[6]  J. Campisi Fragile fugue: p53 in aging, cancer and IGF signaling , 2004, Nature Medicine.

[7]  K. Mohammad,et al.  Modulation of mammalian life span by the short isoform of p53. , 2004, Genes & development.

[8]  Qin M. Chen,et al.  Novel mechanisms of sublethal oxidant toxicity: induction of premature senescence in human fibroblasts confers tumor promoter activity. , 2003, Experimental cell research.

[9]  M. Blasco Mammalian telomeres and telomerase: why they matter for cancer and aging. , 2003, European journal of cell biology.

[10]  Masashi Narita,et al.  Reversal of human cellular senescence: roles of the p53 and p16 pathways , 2003, The EMBO journal.

[11]  S. Lowe,et al.  Rb-Mediated Heterochromatin Formation and Silencing of E2F Target Genes during Cellular Senescence , 2003, Cell.

[12]  A. Melk,et al.  Cell senescence in rat kidneys in vivo increases with growth and age despite lack of telomere shortening. , 2003, Kidney international.

[13]  Judith Campisi,et al.  Cancer and ageing: rival demons? , 2003, Nature Reviews Cancer.

[14]  Joseph A. Buckwalter,et al.  The Role of Chondrocyte Senescence in the Pathogenesis of Osteoarthritis and in Limiting Cartilage Repair , 2003, The Journal of bone and joint surgery. American volume.

[15]  Patricia D. Castro,et al.  Cellular senescence in the pathogenesis of benign prostatic hyperplasia , 2003, The Prostate.

[16]  J. Hoeijmakers,et al.  Aging and Genome Maintenance: Lessons from the Mouse? , 2003, Science.

[17]  J. Foekens,et al.  Aging of stromal-derived human breast fibroblasts might contribute to breast cancer progression , 2003, Thrombosis and Haemostasis.

[18]  J. Campisi Cellular senescence and apoptosis: how cellular responses might influence aging phenotypes , 2003, Experimental Gerontology.

[19]  Matthias Blüher,et al.  Extended Longevity in Mice Lacking the Insulin Receptor in Adipose Tissue , 2003, Science.

[20]  Martin Holzenberger,et al.  IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice , 2003, Nature.

[21]  Goberdhan P Dimri,et al.  Control of the Replicative Life Span of Human Fibroblasts by p16 and the Polycomb Protein Bmi-1 , 2003, Molecular and Cellular Biology.

[22]  D. Schild,et al.  Recombinational DNA repair and human disease. , 2002, Mutation research.

[23]  J. Campisi,et al.  Cancer and aging: a model for the cancer promoting effects of the aging stroma. , 2002, The international journal of biochemistry & cell biology.

[24]  M. Radman,et al.  Specialized DNA Polymerases, Cellular Survival, and the Genesis of Mutations , 2002, Science.

[25]  Bret S. Weinstein,et al.  The reserve-capacity hypothesis: evolutionary origins and modern implications of the trade-off between tumor-suppression and tissue-repair , 2002, Experimental Gerontology.

[26]  Jan Vijg,et al.  Large genome rearrangements as a primary cause of aging , 2002, Mechanisms of Ageing and Development.

[27]  K. Helin,et al.  The role of p53 and pRB in apoptosis and cancer. , 2002, Current opinion in genetics & development.

[28]  B. Herman,et al.  Ageing and apoptosis , 2002, Mechanisms of Ageing and Development.

[29]  J. Campisi,et al.  Telomeres, aging and cancer: In search of a happy ending , 2002, Oncogene.

[30]  D. Dunson,et al.  Mutational fingerprints of aging. , 2002, Nucleic acids research.

[31]  Stephen N. Jones,et al.  p53 mutant mice that display early ageing-associated phenotypes , 2002, Nature.

[32]  Antony M. Carr,et al.  The evolution of diverse biological responses to DNA damage: insights from yeast and p53 , 2001, Nature Cell Biology.

[33]  J. Campisi Cellular senescence as a tumor-suppressor mechanism. , 2001, Trends in cell biology.

[34]  J. Campisi,et al.  Senescent fibroblasts promote epithelial cell growth and tumorigenesis: A link between cancer and aging , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[35]  Mina J. Bissell,et al.  Putting tumours in context , 2001, Nature Reviews Cancer.

[36]  S. Gollapudi,et al.  Functional Decline in Aging and Disease: A Role for Apoptosis , 2001, Journal of the American Geriatrics Society.

[37]  V. Weaver,et al.  Tumour-stromal interactions: Integrins and cell adhesions as modulators of mammary cell survival and transformation , 2001, Breast Cancer Research.

[38]  T. Osler,et al.  Senescence and the healing rates of venous ulcers. , 2001, Journal of vascular surgery.

[39]  K. Vousden,et al.  Regulation and function of the p53 tumor suppressor protein. , 2001, Current opinion in cell biology.

[40]  Elise C. Kohn,et al.  The microenvironment of the tumour–host interface , 2001, Nature.

[41]  Goberdhan P Dimri,et al.  Regulation of cellular senescence by p53. , 2001, European journal of biochemistry.

[42]  V. Paradis,et al.  Replicative senescence in normal liver, chronic hepatitis C, and hepatocellular carcinomas. , 2001, Human pathology.

[43]  M. Shekhar,et al.  Breast stroma plays a dominant regulatory role in breast epithelial growth and differentiation: implications for tumor development and progression. , 2001, Cancer research.

[44]  J. Shay,et al.  Cellular senescence as a tumor-protection mechanism: the essential role of counting. , 2001, Current opinion in genetics & development.

[45]  T. Tlsty,et al.  Know thy neighbor: stromal cells can contribute oncogenic signals. , 2001, Current opinion in genetics & development.

[46]  H. Dvorak,et al.  Differential expression of thymosin β‐10 by early passage and senescent vascular endothelium is modulated by VPF/VEGF: evidence for senescent endothelial cells in vivo at sites of atherosclerosis , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[47]  L. Balducci,et al.  Cancer and age in the USA. , 2001, Critical reviews in oncology/hematology.

[48]  P. Singhal,et al.  Tubular cell senescence and expression of TGF-beta1 and p21(WAF1/CIP1) in tubulointerstitial fibrosis of aging rats. , 2001, Experimental and molecular pathology.

[49]  W. Hahn,et al.  Genes involved in senescence and immortalization. , 2000, Current opinion in cell biology.

[50]  Ronald A. DePinho,et al.  The age of cancer , 2000, Nature.

[51]  Steven N. Austad,et al.  Why do we age? , 2000, Nature.

[52]  L. Guarente,et al.  Genetic pathways that regulate ageing in model organisms , 2000, Nature.

[53]  M J Bissell,et al.  The influence of the microenvironment on the malignant phenotype. , 2000, Molecular medicine today.

[54]  M. Benson,et al.  Expression of senescence-associated beta-galactosidase in enlarged prostates from men with benign prostatic hyperplasia. , 2000, Urology.

[55]  G. Lithgow,et al.  Natural selection: Evolution of lifespan in C. elegans , 2000, Nature.

[56]  M. Serrano,et al.  Tumor suppressors and oncogenes in cellular senescence☆ , 2000, Experimental Gerontology.

[57]  G. Enders,et al.  p16INK4a can initiate an autonomous senescence program , 2000, Oncogene.

[58]  M. Barcellos-Hoff,et al.  Irradiated mammary gland stroma promotes the expression of tumorigenic potential by unirradiated epithelial cells. , 2000, Cancer research.

[59]  R. Reddel The role of senescence and immortalization in carcinogenesis. , 2000, Carcinogenesis.

[60]  J. Gray,et al.  Genome changes and gene expression in human solid tumors. , 2000, Carcinogenesis.

[61]  R. DePinho,et al.  A critical role for telomeres in suppressing and facilitating carcinogenesis. , 2000, Current opinion in genetics & development.

[62]  R. Faragher Cell senescence and human aging: where's the link? , 2000, Biochemical Society transactions.

[63]  Goberdhan P Dimri,et al.  Regulation of a Senescence Checkpoint Response by the E2F1 Transcription Factor and p14ARF Tumor Suppressor , 2000, Molecular and Cellular Biology.

[64]  G. Roth,et al.  Cellular proliferation potential during aging and caloric restriction in rhesus monkeys (Macaca mulatta) , 1999, Journal of cellular physiology.

[65]  J. Handa,et al.  Senescence-associated β-galactosidase histochemistry for the primate eye , 1999 .

[66]  R. DePinho,et al.  The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus , 1999, Nature.

[67]  C. Prives,et al.  The p53 pathway , 1999, The Journal of pathology.

[68]  D. Woods,et al.  Senescence of human fibroblasts induced by oncogenic Raf. , 1998, Genes & development.

[69]  C. Sherr,et al.  Tumor surveillance via the ARF-p53 pathway. , 1998, Genes & development.

[70]  G. Peters,et al.  Inhibitors of cyclin-dependent kinases induce features of replicative senescence in early passage human diploid fibroblasts , 1998, Current Biology.

[71]  G. Adami,et al.  Agents that cause DNA double strand breaks lead to p16INK4a enrichment and the premature senescence of normal fibroblasts , 1998, Oncogene.

[72]  D. Wynford‐Thomas,et al.  Reinitiation of DNA Synthesis and Cell Division in Senescent Human Fibroblasts by Microinjection of Anti-p53 Antibodies , 1998, Molecular and Cellular Biology.

[73]  M. Skobe,et al.  Tumorigenic conversion of immortal human keratinocytes through stromal cell activation. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[74]  S. Aaronson,et al.  Wild-type p53 triggers a rapid senescence program in human tumor cells lacking functional p53. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[75]  J. Campisi,et al.  Aging and Cancer: The Double‐Edged Sword of Replicative Senescence , 1997, Journal of the American Geriatrics Society.

[76]  S. Lowe,et al.  Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4a , 1997, Cell.

[77]  G. Martin,et al.  The genetics of aging. , 2003, Annual review of genomics and human genetics.

[78]  P. Enright,et al.  Sleep Disturbance, Psychosocial Correlates, and Cardiovascular Disease in 5201 Older Adults: The Cardiovascular Health Study , 1997, Journal of the American Geriatrics Society.

[79]  B. Howard,et al.  Human fibroblast commitment to a senescence-like state in response to histone deacetylase inhibitors is cell cycle dependent , 1996, Molecular and cellular biology.

[80]  O. Pereira-smith,et al.  Replicative Senescence: Implications for in Vivo Aging and Tumor Suppression , 1996, Science.

[81]  J. Campisi,et al.  Replicative Senescence: An Old Lives' Tale? , 1996, Cell.

[82]  G. Martin Somatic mutagenesis and antimutagenesis in aging research. , 1996, Mutation research.

[83]  J. Bishop Cancer: the rise of the genetic paradigm. , 1995, Genes & development.

[84]  B. Ames,et al.  Oxidative DNA damage and senescence of human diploid fibroblast cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[85]  G. Wahl,et al.  DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. , 1994, Genes & development.

[86]  R. Pignolo,et al.  Replicative senescence of human fibroblast-like cells in culture. , 1993, Physiological reviews.

[87]  C B Harley,et al.  Telomere end-replication problem and cell aging. , 1992, Journal of molecular biology.

[88]  R. Miller,et al.  Gerontology as oncology. Research on aging as the key to the understanding of cancer , 1991, Cancer.

[89]  R. Sager Senescence as a mode of tumor suppression. , 1991, Environmental health perspectives.

[90]  J. Shay,et al.  Defining the molecular mechanisms of human cell immortalization. , 1991, Biochimica et biophysica acta.

[91]  H. Gabius,et al.  Detection and functions of mammalian lectins--with emphasis on membrane lectins. , 1991, Biochimica et biophysica acta.

[92]  Thomas E. Johnson,et al.  Evolutionary biology of aging , 1990 .

[93]  L. Hayflick THE LIMITED IN VITRO LIFETIME OF HUMAN DIPLOID CELL STRAINS. , 1965, Experimental cell research.

[94]  George C. Williams,et al.  PLEIOTROPY, NATURAL SELECTION, AND THE EVOLUTION OF SENESCENCE , 1957, Science of Aging Knowledge Environment.

[95]  J. Shay,et al.  Telomeres and Telomerase: Implications for Cancer and Aging , 2001, Radiation research.

[96]  N. Ellis,et al.  DNA helicases, genomic instability, and human genetic disease. , 2000, Annual review of genomics and human genetics.

[97]  A. Knudson,et al.  Chasing the cancer demon. , 2000, Annual review of genetics.

[98]  John Calvin Reed Mechanisms of apoptosis avoidance in cancer. , 1999, Current opinion in oncology.

[99]  J. Handa,et al.  Senescence-associated beta-galactosidase histochemistry for the primate eye. , 1999, Investigative ophthalmology & visual science.

[100]  A. Simpson,et al.  Evolution and the inevitability of human cancer. , 1998, Seminars in cancer biology.

[101]  K. Kinzler,et al.  Cancer-susceptibility genes. Gatekeepers and caretakers. , 1997, Nature.

[102]  W. Birchmeier,et al.  Epithelial-mesenchymal transitions in development and tumor progression. , 1995, EXS.

[103]  G. Cunha,et al.  Stromal regulation of epithelial function. , 1991, Cancer treatment and research.

[104]  R. Bosch,et al.  Pathogenesis of benign prostatic hyperplasia. , 1991, European urology.

[105]  Edward L. Schneider,et al.  Handbook of the Biology of Aging , 1990 .

[106]  J Salvage,et al.  A matter of life and death. , 1981, Nursing times.

[107]  I. M. Neiman,et al.  [Inflammation and cancer]. , 1974, Patologicheskaia fiziologiia i eksperimental'naia terapiia.

[108]  L. Hayflick,et al.  THE LIMITED IN VITRO LIFETIME OF HUMAN DIPLOID CELL STRAINS 1 , 1964 .